Accelerated vs. Step Up Endoscopic Management of Walled-Off Necrosis: A Cost Analysis
Endoscopy · 01.06.2026 · 58 (S 03 S 03) · S70-S71
DOI: 10.1055/s-0046-1820751 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.06.2026. Verfasst von G A Olsen und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Aims
Pancreatic walled-off necrosis (WON) has typically been managed using a step-up strategy, in which endoscopic necrosectomy (EN) is performed only if patients fail to improve after initial drainage. Recent randomized controlled trials (RCTs) have suggested that an accelerated approach with upfront EN at the index procedure and subsequent necrosectomy until resolution of the WON may improve clinical outcomes. This study aimed to evaluate the healthcare costs associated with accelerated versus step-up management of WON, and to identify which cost categories primarily drive any differences between strategies [ 1 ] [ 2 ].
Methods
This cost analysis used data from two RCTs conducted at Copenhagen University Hospital Hvidovre between August 30, 2019 and April 19, 2024. Patients were managed according to either the step-up protocol or an accelerated protocol. Initial drainage in the step-up group used either double-pigtail stents (DPS) or lumen-apposing metal stents (LAMS); all accelerated-protocol patients received LAMS. Cost data were extracted from the hospital accounting system and categorized into hospitalization, procedures, devices, imaging, medication, and outpatient care. Multivariable analyses were adjusted for baseline characteristics and calendar time. Step-up patients were further stratified by stent type (step-up–LAMS, step-up–DPS). Results are presented as adjusted mean cost differences with 95% confidence intervals (CI) ([ Table 1 ]).
Results
A total of 64 patients were included: 12 managed with the accelerated protocol and 52 with the step-up protocol. Baseline characteristics were comparable between groups.In the primary comparison, the accelerated group had a significantly lower adjusted mean total cost than the step-up group (€41,656 vs €73,999), corresponding to an adjusted mean difference of –€32,343 (95%CI –€54,838 to –€5,616; p=0.0122). Category-level decomposition showed that hospitalization costs were the main contributors to the cost difference. When stratifying the step-up cohort by stent type, the accelerated strategy remained significantly less costly than step-up–LAMS (–€35,404; 95%CI –€59,052 to –€5,948; p=0.0372). In contrast, the cost difference between accelerated and step-up–DPS was smaller (–€22,700; 95%CI –€57,111 to €9,541) and insignificant.Device-related costs were highest in the accelerated group (€6,174), followed by step-up–LAMS (€4,753) and step-up–DPS (€3,127), though these differences did not reach statistical significance after correction for multiple comparisons. Device expenditures represented the only category in which the accelerated strategy exceeded the cost of step-up management.
Conclusions
Accelerated endoscopic management of WON was associated with substantially lower overall treatment costs compared with the conventional step-up approach, primarily due to reduced hospitalization expenses. The findings emphasize that clinical improvements demonstrated with an accelerated management also translate into meaningful reductions in resource utilization. Table 1 Detailed breakdown of costs in accelerated vs. step-up groups Category Accelerated (adjusted mean) Step-up (adjusted mean) Adjusted mean difference 95% CI p -value Overall cost €41,656 €73,999 -€32,343 -€54,838 to -€5,616 0.0122 Hospitalization €22,145 €46,912 -€24,767 -€38,427 to -€8,482 0.0224 Endoscopy time €2,880 €3,572 -€693 -€2,221 to €1,410 1.00 Endoscopy devices €6,157 €3,315 €2,842 €815 to €5,275 0.0882 Surgery €0 €733 -€733 -€1,520 to -€207 1.00 Antibiotics €4,887 €10,236 -€5,349 -€10,758 to €834 0.273 Parenteral nutrition €574 €1,758 -€1,184 -€2,053 to -€184 0.0882 Radiology €1,235 €2,875 -€1,640 -€2,556 to -€569 0.0231 Follow-up €4,003 €4,642 -€640 -€5,057 to €4,385 1.00 Publication History Article published online: 05 June 2026 © 2026. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Zitieren
APA
Olsen, G. A., Neermark, S., Al-Ghazal, A. A., Schmidt, P. N., Jensen, J. F., Timmner, J. S., Novovic, S., & Karstensen, J. G. (2026). Accelerated vs. Step Up Endoscopic Management of Walled-Off Necrosis: A Cost Analysis. Endoscopy, 58(S 03 S 03), S70-S71. https://doi.org/10.1055/s-0046-1820751
Vancouver
Olsen GA, Neermark S, Al-Ghazal AA, Schmidt PN, Jensen JF, Timmner JS, et al. Accelerated vs. Step Up Endoscopic Management of Walled-Off Necrosis: A Cost Analysis. Endoscopy. 2026;58(S 03 S 03):S70-S71. doi:10.1055/s-0046-1820751
BibTeX
@article{Olsen2026,
author = {Olsen, G A and Neermark, S and Al-Ghazal, AZ A and Schmidt, P N and Jensen, J F and Timmner, J S and Novovic, S and Karstensen, J G},
title = {Accelerated vs. Step Up Endoscopic Management of Walled-Off Necrosis: A Cost Analysis},
journal = {Endoscopy},
year = {2026},
volume = {58},
number = {S 03 S 03},
pages = {S70--S71},
doi = {10.1055/s-0046-1820751}
}
EUVIMED